CLINICAL_TRIALS
trial_result
· 2021-03-11
Clinical Trial Update: Olaparib in People With Malignant Mesothelioma [Phase 2]
Summary
Phase 2 trial update on olaparib in malignant mesothelioma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2021-03-11